Monday, December 18, 2017

Banner Image - Patient Safety, Product Integrity, Fair Pricing

Influenza Vaccine Coverage Is Highest Among Workplaces with Vaccination Requirements

In this Issue


•	IVIG/Albumin Supply Index
•	Open Market Pricing
•	New Products from FFF
•	Current Medicare IVIG / SCIG Rates
•	Resources
•	Subscribe to IG Living and BioSupply Trends Quarterly

An Internet panel survey of healthcare personnel (HCP) from March 28, 2017, through April 19, 2017, showed the overall influenza vaccination coverage estimate among HCP was 78.6 percent in the 2016-17 season, an increase of 15 percentage points since the 2010-11 season, but similar to the 2013-14 through 2015-16 seasons, with the highest coverage among those whose workplace had vaccination requirements. [ read more ]

IVIG Safe and Effective for Treating SFPN

A study conducted to assess the safety and efficacy of “apparently autoimmune" small fiber polyneuropathy (aaSFPN) has found intravenous immune globulin (IVIG) reduces pain and improves organ function. [ read more ]

Study Finds Antibiotics Can Weaken the Immune System

Researchers at Harvard, MIT, the Wyss Institute for Biologically Inspired Engineering and the Broad Institute, have found antibiotics can work against the body by weakening the immune system’s ability to fight off bacteria. [ read more ]

Industry News

From CSL Behring

During routine inspection of retained AlbuRx 25% samples, CSL Behring noted the potential for fading print with more effect on the expiration dating on the patient tear-off portion of the label on 50 mL and 100 mL vial sizes. While CSL Behring is taking no action with product on the market, it is addressing the print settings to ensure readability throughout the shelf life of the product. [ read more ]

From GlaxoSmithKline

Nucala (mepolizumab, GlaxoSmithKline) has been approved by the U.S. Food and Drug Administration to treat eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that causes vasculitis. [ read more ]

From Mylan

Mylan’s Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as a biosimilar to Genentech’s Herceptin (trastuzumab) for the treatment of patients with HER2-overexpressing breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma). [ read more ]

IVIG & Albumin Supply Index

IVIG and Albumin Supply Index from September 2017 - December 2017

Log in to BioSupply for IVIG and Albumin Product Pricing

MyFluVaccine Loyalty Program

Want priority access on flu vaccines
for the 2019-2020 season?

Then take advantage of our NEW inclusive MFV Loyalty Program and enroll for the 2019-2020 season when you go to book your flu vaccine orders for the 2018-2019 season through MyFluVaccine.com

Priority access on advance released flu vaccines
No minimum purchase
Hassle-free
Guaranteed booking for the products you need

Current Medicare IVIG / SCIG Rates

Rates per gram are effective Oct. 1, 2017, through Dec. 31, 2017.

Product	J Codes	ASP + 6% (before sequester)	ASP + 4.3%* (after sequester)
IVIG
Carimune NF	J1566	$68.56	$67.46
Flebogamma	J1572	$59.67	$58.71
Gammagard S/D	J1566	$68.56	$67.46
Gammaplex	J1557	$82.16	$80.84
Octagam	J1568	$73.24	$72.06
Privigen	J1459	$77.01	$75.78
SCIG
CUVITRU **	J3490/J3590/J7799	-	-
Hizentra	J1559	$98.13	$96.56
HyQvia	J1575	$131.36	$129.25
IVIG / SCIG
Gammagard Liquid	J1569	$79.57	$78.29
Gammaked	J1561	$77.89	$76.64
Gamunex-C	J1561	$77.89	$76.64

*Reflects 2% sequestration reduction applied to 80% Medicare payment portion as required under Budget Control Act of 2011.

Log in to BioSupply for Immune Globulin Products

Resources

FFF customers may order the following complementary resources to help you with your practice:


•	IG Immune Globulin (Human)
•	Hyperimmune Globulins
•	Anti-Inhibitor, Factor VIIa & IX
•	Factor VIII & von Willebrand Factor
•	Seasonal Influenza Vaccine

Subscribe to IG Living

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.

Subscribe to BioSupply
Trends Quarterly

BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.

This email was sent by: %%Member_Busname%%, %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
Manage preferences: Privacy Policy, Update Profile, Unsubscribe.